Search results
Two Philadelphia-area biotech firms report progress on pursuit of a hepatitis B cure - Philadelphia...
The Business Journals· 3 days agoTwo local life sciences companies reported progress this week on their efforts to develop a cure for...
Magistrate Sides With Defendants in Inmate's Claims in Failure to Treat Hep C | Law.com
Law.com· 6 days agoIn a memorandum opinion and recommendation issued May 28, Auld found that physician assistant Karen...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post via Yahoo News· 2 days agoROCK HILL, S.C. - Kashyap Patel looked forward to his team’s Friday lunches. All the doctors from...
Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus - Atea...
Benzinga· 4 days agoAtea Pharmaceuticals Inc AVIR announced Wednesday new data from the lead-in cohort (n=60) of the company’s ongoing Phase 2 combination study of bemnifosbuvir for hepatitis ...
Man sentenced to 6.5 years in prison for human trafficking case
FOX 12 Oregon· 4 days agoOn Wednesday, a man arrested in a human trafficking sting operation was sentenced to 80 months in...
Cost and Vosevi: How to find savings, lower costs, and more
Medical News Today· 6 days agoThe cost of the drug with and without insurance can depend on several factors, such as whether...
Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress...
The Tomahawk· 2 days agoNew translational data demonstrate that BRII-179-induced immune responses are associated with high HBsAg reduction in a subset of participants with chronic HBV infection
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
Zacks via Yahoo Finance· 3 days ago(GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea...
Salem Hospital says none test positive after infection warning
The Salem News· 6 days agoNone of the 385 patients who have been tested after an infection warning at Salem Hospital have tested positive for HIV or an active hepatitis B or hepatitis</ ...
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
Zacks· 3 days agoThis change outpaced the S&P 500's 0.11% loss on the day. Heading into today, shares of the HIV and hepatitis C drugmaker had lost 1.13% over the past month ...